癌症老年人报告的症状严重程度及其对生存预后的影响
1Department of Palliative Medicine, Tan Tock Seng Hospital, Singapore.; Department of Geriatric Medicine, Institute of Geriatrics and Active Ageing, Tan Tock Seng Hospital, Singapore.; Palliative Care Centre for Excellence in Research and Education, Singapore.
Journal of geriatric oncology
|September 27, 2024
概括
患有癌症的老年人报告症状较少,影响生存预后. 然而,高级癌症预后模型 (PRO-MAC) 在所有年龄组中仍然有效.
科学领域:
- 老年瘤学 老年瘤学
- 抚慰性医学是一种缓解性医学.
- 癌症预后 癌症预后
背景情况:
- 症状负担是癌症生存预后的关键.
- 与年轻患者相比,老年人可能会低于报告症状严重程度.
- 年龄对症状报告和预后的影响需要进一步研究.
研究的目的:
- 为了研究年龄如何影响晚期癌症患者的症状严重程度.
- 为了确定与年龄相关的症状报告的预后影响.
- 评估不同年龄组的晚期癌症预后模型 (PRO-MAC) 的有效性.
主要方法:
- 在四个年龄组 (<65,65-74,75-84,≥85) 中比较症状严重程度 (ESAS-r) 和PRO-MAC模型意义.
- 使用多变量Cox比例危险回归和日志等级测试.
- 包括840名患有无法治愈的癌症的患者,由息医学审查.
主要成果:
- 老年人报告症状得分明显较低 (疼痛,疲劳,焦虑,幸福感,ESAS-r总结得分).
- 较高比例的老年人报告没有症状.
- 只有在年轻人群中,ESAS-r总结得分是显著的预后因素;PRO-MAC在所有年龄段仍然适用.
结论:
- 老年癌症患者的症状负担降低可能会影响仅基于症状的生存预后.
- 多维PRO-MAC模型对晚期癌症的老年患者的预后有效.
- 对于更好地捕捉老年人症状严重程度的工具,需要进一步的研究,以改善预后.
相关概念视频
Cancer Survival Analysis
329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329
Psychoneuroimmunology: Diabetes and Cancer
25
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
25
Comparing the Survival Analysis of Two or More Groups
156
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
156
Assumptions of Survival Analysis
101
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
101
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K


